Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

In a recent study published in the US Centers for Disease Control and Prevention (CDC) emerging infectious diseases In the journal, researchers investigate the cross-reactivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with pre-pandemic malaria-exposed sera samples collected from Cambodia. Stady: SARS-CoV-2 cross-reactivity in pre-pandemic serum of malaria-infected subjects in rural areas, Cambodia. Image … Read more

“Nocebo effect” accounts for 76% of all adverse events in the COVID-19 vaccine trial group

The placebo effect is a phenomenon known to improve a person’s physical or mental health after taking a treatment with no pharmacological benefit – a sugar pill, or a syringe filled with saline, for example. While the biological, psychological, and genetic underpinnings of the placebo effect are not well understood, some theories point to expectations … Read more

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The novel coronavirus 2019 (COVID-19) pandemic was caused by a new coronavirus, i.e., severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The RNA virus causes mild to severe symptoms and has a high transmission rate. In severe infection, patients often have a highly inflammatory response, which has been associated with morbidity and mortality due to COVID-19 disease. … Read more